Invention Grant
- Patent Title: RNA encoding a therapeutic protein
-
Application No.: US17359902Application Date: 2021-06-28
-
Publication No.: US12227549B2Publication Date: 2025-02-18
- Inventor: Mariola Fotin-Mleczek , Ingmar Hoerr
- Applicant: CureVac SE
- Applicant Address: DE Tübingen
- Assignee: CureVac SE
- Current Assignee: CureVac SE
- Current Assignee Address: DE Tübingen
- Agency: Parker Highlander PLLC
- Priority: WOPCT/EP2016/060111 20160504
- Main IPC: C07H21/02
- IPC: C07H21/02 ; A61K31/7088 ; A61K31/7105 ; A61K45/06 ; A61K48/00 ; C07H21/04 ; C07K14/505 ; C12N15/113 ; A61K38/00
Abstract:
The present invention relates to an RNA encoding a therapeutic protein. In particular, the present invention relates to RNA suitable for use as a medicament. The present invention concerns such novel RNA as well as compositions and kits comprising the RNA. Furthermore, the present invention relates to the RNA, compositions or kits as disclosed herein for use as a medicament. The present invention also provides the use of the RNA, compositions or kits as disclosed herein for increasing the expression of said encoded protein, in particular in gene therapy.
Public/Granted literature
- US20220025369A1 RNA ENCODING A THERAPEUTIC PROTEIN Public/Granted day:2022-01-27
Information query
